2025年心臟標記檢測全球市場報告

預計未來幾年心臟標記檢測的市場規模將快速成長。到 2029 年，這一數字將成長至 105.6 億美元，年複合成長率（CAGR）為 10.1%。預測期內的成長歸因於心血管疾病發病率的上升、策略聯盟和夥伴關係數量的增加、研發舉措的增加、優惠的報銷政策以及對照護現場（POC）測試的需求的不斷成長。預測期內的關鍵趨勢包括先進診斷技術、自動分析儀、先進心臟標記檢測方法、數位健康技術和整合技術的出現。

心血管疾病的日益普及預計將在未來幾年推動心臟標記檢測市場的成長。心血管疾病 (CVD) 會影響心臟和血管，包括冠狀動脈疾病、心臟衰竭和中風等疾病。不健康飲食、缺乏運動、吸菸、過量飲酒和空氣污染等因素導致心血管疾病病例增加。心臟標記檢測透過檢測心肌損傷時釋放的特定生物標記物，在診斷心血管疾病、評估其嚴重程度和監測其治療進展中發揮重要作用。例如，美國心臟協會在2024年1月報告稱，2023年年齡調整後的心血管疾病死亡率增加了4.0%，從每10萬人224.4人增加到233.3人。此外，2021 年美國有 20,114 人死於心臟麻痹。因此，心血管疾病發生率的上升推動了對心臟標記檢測的需求。

心臟標記檢測市場的主要企業正專注於開發先進產品，例如心臟檢測，以提供有關心臟健康和功能的準確和有價值的資訊。這些檢測是診斷測試，旨在測量血液和其他樣本中的生物標記和其他指標，以幫助評估心臟功能、診斷心血管疾病和評估心臟相關疾病的風險。例如，2023年10月，中國醫療設備公司邁瑞推出了肌鈣蛋白i（hs-cTnI）和NT-proBNP心臟生物標記。 hs-cTnI檢測法以其高靈敏度、精確度和可靠性而著稱，在檢測極限 (LoD) 和第 99 個百分位參考上限 (URL) 之間實現 93% 的檢測率，並且在第 99 個 URL 處保持 5% 或更低的不精確變異係數 (CV)，超出最低要求。這使得它對於檢測心肌損傷極為有用。邁瑞的 NT-proBNP檢測法是心臟衰竭領先的心臟標記物，具有較高的準確度（CV<=5%），並最大限度地減少了對 55 種常見心臟藥物的干擾，確保準確檢測和管理心臟衰竭。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 世界心臟標記研究PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球心臟標記檢測市場：成長率分析
• 全球心臟標記檢測市場表現：規模與成長，2019-2024
• 全球心臟標記檢測市場預測：規模與成長，2024-2029 年，2034 年
• 全球心臟標記檢測總目標市場（TAM）

第6章市場區隔

• 全球心臟標記檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 試劑和套件
• 裝置
• 全球心臟標記檢測市場（按生物標記類型、表現和預測）2019-2024 年、2024-2029 年、2034 年
• 肌鈣蛋白 I 和 T
• 肌酸激酶同功酶（CK-MB）
• 利鈉肽
• 肌紅蛋白
• 高敏C反應蛋白
• 其他心臟生物標記
• 全球心臟標記檢測市場：應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 實驗室測試設施
• 就地檢驗實驗室
• 學術機構
• 全球心臟標記檢測市場按試劑和套件類型、性能和預測進行細分，2019-2024 年、2024-2029 年、2034 年
• 肌鈣蛋白檢測套組
• B型利鈉肽（BNP）檢測套組
• 肌酸激酶MB（CK-MB）檢測套組
• 肌紅蛋白檢測套組
• 其他心臟生物標記試劑
• 全球心臟標記檢測市場，按儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 就地檢驗設備
• 自動化分析設備
• 免疫檢測系統
• 可攜式診斷設備

第7章 區域和國家分析

• 全球心臟標記檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球心臟標記檢測市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 心臟標記檢測市場：競爭格局
• 心臟標記檢測市場：公司簡介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Becton Dickinson and Company
• Laboratory Corporation of America Holdings
• Quest Diagnostics Inc.
• Tosoh Corporation
• bioMerieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Guangzhou Wondfo Biotech Co. Ltd.
• Randox Laboratories Ltd.
• Getein Biotech Inc.
• Fujirebio Inc.
• Mayo Clinic Laboratories
• Kainos Medicine Inc.
• Alere Inc.
• Nano-Ditech Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年心臟標記檢測市場：提供新機會的國家
• 2029年心臟標記檢測市場：細分市場帶來新機會
• 2029年心臟標記檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Cardiac marker testing involves a series of diagnostic tests designed to measure specific substances in the blood that signal damage or stress to the heart. These markers, often proteins or enzymes, are released into the bloodstream when the heart muscle is injured. Cardiac marker tests are vital for diagnosing and assessing conditions such as myocardial infarction (heart attack), heart failure, and other heart-related diseases.

The primary products used in cardiac marker testing include reagents, kits, and instruments. Reagents and kits are crucial components in these tests, containing the necessary chemicals and materials for conducting diagnostics. They provide various biomarkers, such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high-sensitivity C-reactive protein, and others, and are utilized in laboratory testing facilities, point-of-care testing facilities, and academic institutions.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $6.52 $ billion in 2024 to $7.19 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in geriatric population, rise in educational campaigns, increasing awareness, rising healthcare infrastructure, and rising patient population.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $10.56 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising incidences of cardiovascular diseases, increasing strategic collaborations and partnerships, increasing research and development initiatives, favorable reimbursement policies and rising demand for point-of-care (POC) testing. Major trends in the forecast period include advanced diagnostic technologies, automated analyzers, advanced cardiac marker testing assays, digital health technologies, and emergence of integrative technologies.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac marker testing market in the coming years. Cardiovascular diseases (CVDs), encompassing conditions such as coronary artery disease, heart failure, and stroke, affect the heart and blood vessels. Factors such as unhealthy diets, lack of physical activity, tobacco use, excessive alcohol consumption, and air pollution contribute to the rise in CVD cases. Cardiac marker testing plays a crucial role in diagnosing cardiovascular diseases, assessing their severity, and monitoring treatment progress by detecting specific biomarkers released during myocardial injury. For instance, the American Heart Association reported in January 2024 that the age-adjusted death rate from cardiovascular disease increased by 4.0%, from 224.4 per 100,000 in 2023 to 233.3 per 100,000. Additionally, sudden cardiac arrest accounted for 20,114 deaths in the U.S. in 2021. As a result, the growing incidence of cardiovascular diseases is fueling the demand for cardiac marker testing.

Leading companies in the cardiac marker testing market are focusing on the development of advanced products, such as cardiac assays, to provide accurate and valuable information regarding heart health and function. These assays are diagnostic tests designed to measure biomarkers or other indicators in blood or other samples, helping to assess heart function, diagnose cardiovascular diseases, and evaluate the risk of heart-related conditions. For example, in October 2023, Mindray, a medical device company based in China, introduced the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay is notable for its high sensitivity, precision, and reliability, surpassing the minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL), and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL. This makes it highly effective in detecting myocardial injury. Mindray's NT-proBNP assay is a key cardiac marker for heart failure, offering high precision with a CV of <=5% and minimizing interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.

In August 2024, VION Biosciences, a US-based life sciences platform, acquired Ansh Labs for an undisclosed amount. This acquisition is intended to bolster VION Biosciences' presence in the diagnostic sector, integrate advanced technologies, and expand its product offerings in immunoassay development. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics

North America was the largest region in the cardiac marker testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Instruments
• 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Cardiac Biomarkers
• 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
• Subsegments:
• 1) By Reagents and Kits: Troponin Test Kits; B-type Natriuretic Peptide (BNP) Test Kits; Creatine Kinase-MB (CK-MB) Test Kits; Myoglobin Test Kits; Other Cardiac Biomarker Reagents
• 2) By Instruments: Point-of-Care Testing Devices; Automated Analyzers; Immunoassay Systems; Portable Diagnostic Devices
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Marker Testing Market Characteristics

3. Cardiac Marker Testing Market Trends And Strategies

4. Cardiac Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Marker Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Marker Testing Market Growth Rate Analysis
• 5.4. Global Cardiac Marker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Marker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Marker Testing Total Addressable Market (TAM)

6. Cardiac Marker Testing Market Segmentation

• 6.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Instruments
• 6.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Troponin I And T
• Creatine Kinase-MB (CK-MB)
• Natriuretic Peptide
• Myoglobin
• High-Sensitivity C-Reactive Protein
• Other Cardiac Biomarkers
• 6.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing Facilities
• Point-Of-Care Testing Facilities
• Academic Institutions
• 6.4. Global Cardiac Marker Testing Market, Sub-Segmentation Of Reagents and Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Troponin Test Kits
• B-type Natriuretic Peptide (BNP) Test Kits
• Creatine Kinase-MB (CK-MB) Test Kits
• Myoglobin Test Kits
• Other Cardiac Biomarker Reagents
• 6.5. Global Cardiac Marker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point-of-Care Testing Devices
• Automated Analyzers
• Immunoassay Systems
• Portable Diagnostic Devices

7. Cardiac Marker Testing Market Regional And Country Analysis

• 7.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Marker Testing Market

• 8.1. Asia-Pacific Cardiac Marker Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Marker Testing Market

• 9.1. China Cardiac Marker Testing Market Overview
• 9.2. China Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Marker Testing Market

• 10.1. India Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Marker Testing Market

• 11.1. Japan Cardiac Marker Testing Market Overview
• 11.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Marker Testing Market

• 12.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Marker Testing Market

• 13.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Marker Testing Market

• 14.1. South Korea Cardiac Marker Testing Market Overview
• 14.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Marker Testing Market

• 15.1. Western Europe Cardiac Marker Testing Market Overview
• 15.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Marker Testing Market

• 16.1. UK Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Marker Testing Market

• 17.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Marker Testing Market

• 18.1. France Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Marker Testing Market

• 19.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Marker Testing Market

• 20.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Marker Testing Market

• 21.1. Eastern Europe Cardiac Marker Testing Market Overview
• 21.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Marker Testing Market

• 22.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Marker Testing Market

• 23.1. North America Cardiac Marker Testing Market Overview
• 23.2. North America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Marker Testing Market

• 24.1. USA Cardiac Marker Testing Market Overview
• 24.2. USA Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Marker Testing Market

• 25.1. Canada Cardiac Marker Testing Market Overview
• 25.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Marker Testing Market

• 26.1. South America Cardiac Marker Testing Market Overview
• 26.2. South America Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Marker Testing Market

• 27.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Marker Testing Market

• 28.1. Middle East Cardiac Marker Testing Market Overview
• 28.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Marker Testing Market

• 29.1. Africa Cardiac Marker Testing Market Overview
• 29.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Marker Testing Market Competitive Landscape
• 30.2. Cardiac Marker Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Marker Testing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Laboratory Corporation of America Holdings
• 31.3. Quest Diagnostics Inc.
• 31.4. Tosoh Corporation
• 31.5. bioMerieux SA
• 31.6. Sysmex Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Guangzhou Wondfo Biotech Co. Ltd.
• 31.9. Randox Laboratories Ltd.
• 31.10. Getein Biotech Inc.
• 31.11. Fujirebio Inc.
• 31.12. Mayo Clinic Laboratories
• 31.13. Kainos Medicine Inc.
• 31.14. Alere Inc.
• 31.15. Nano-Ditech Corporation

32. Global Cardiac Marker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

34. Recent Developments In The Cardiac Marker Testing Market

35. Cardiac Marker Testing Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Marker Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Marker Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Marker Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer